Drug Designing: Open Access
Open Access

ISSN: 2169-0138

Citations Report

Citations Report - Drug Designing: Open Access [127 Articles]

The articles published in Drug Designing: Open Access have been cited 127 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Drug Designing: Open Access.

Jian C, Zhang P, Ma J, Jian S, Zhang Q, Liu B, et al. The roles of fatty-acid modification in the activity of the anticancer peptide R-lycosin-I. Molecular pharmaceutics. 2018;15: 4612-20. View at Publisher View at Google Scholar
Shoombuatong W, Schaduangrat N, Nantasenamat C. Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI journal. 2018;7: 734. View at Publisher View at Google Scholar
Gelain A, Mori M, Meneghetti F, Villa S. Signal transducer and activator of transcription protein 3 (STAT3): An update on its direct inhibitors as promising anticancer agents. Current medicinal chemistry. 2019. View at Publisher View at Google Scholar
Beebe JD, Liu JY, Zhang JT. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?. Pharmacology & therapeutics. 2018;191: 74-91. View at Publisher View at Google Scholar
Chen X, Guo L, Ma Q, Chen W, Fan W, Zhang J. Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent Î²-Carbolines as Potential Anticancer Agents. Molecules. 2019;24 :2950. View at Publisher View at Google Scholar
Deokar H, Deokar M, Wang W, Zhang R, Buolamwini JK. QSAR studies of new pyrido [3, 4-b] indole derivatives as inhibitors of colon and pancreatic cancer cell proliferation. Medicinal Chemistry Research. 2018 ;27: 2466-81. View at Publisher View at Google Scholar
Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. Journal of nanobiotechnology. 2019;17: 90. View at Publisher View at Google Scholar
Kang KW, Song MG. Organic Nanomaterials: Liposomes, Albumin, Dendrimer, Polymeric. Radionanomedicine: Combined Nuclear and Nanomedicine. 2018: 105. View at Publisher View at Google Scholar
Dias AP, da Silva Santos S, da Silva JV, Parise Filho R, Ferreira EI, El Seoud O, et al. Dendrimers in the context of nanomedicine. International Journal of Pharmaceutics. 2019 : 118814. View at Publisher View at Google Scholar
Kang KW, Song MG. Organic Nanomaterials: Liposomes, Albumin, Dendrimer, Polymeric Nanoparticles. InRadionanomedicine 2018. View at Publisher View at Google Scholar
Dias AP, da Silva Santos S, da Silva JV, Parise Filho R, Ferreira EI, El Seoud O, et al. Dendrimers in the context of nanomedicine. International Journal of Pharmaceutics. 2019;20: 118814. View at Publisher View at Google Scholar
Satarupa M, Aruna V, Gayathri R. Villainous Effect of Sun and Goodness of Evefresh. Skin Diseases & Skin Care. 2017. View at Publisher View at Google Scholar
Rao MS, Varma YN. Journal of Pharmaceutical and Scientific Innovation. View at Publisher View at Google Scholar
Kwofie SK, Broni E, Teye J, Quansah E, Issah I, Wilson MD,et al. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24. Computers in biology and medicine. 2019;113: 103414. View at Publisher View at Google Scholar
Armando R, Mengual GÃ³mez D, Juritz E, Lorenzano Menna P, Gomez D. Homology model and docking-based virtual screening for ligands of human dyskerin as new inhibitors of telomerase for cancer treatment. International journal of molecular sciences. 2018;19: 3216. View at Publisher View at Google Scholar
Kwofie S, Dankwa B, Odame E, Agamah F, Doe L, Teye J, et al. In silico screening of isocitrate lyase for novel anti-buruli ulcer natural products originating from Africa. Molecules View at Publisher View at Google Scholar
Pastor-Anglada M, PÃ©rez-Torras S. Who is who in adenosine transport. Frontiers in pharmacology. 2018;9. View at Publisher View at Google Scholar
Tahlan S, Kumar S, Ramasamy K, Lim SM, Shah SA, Mani V, et al. In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents. BMC chemistry. 2019;13: 90. View at Publisher View at Google Scholar
Kumar S, Sharma D, Narasimhan B, Ramasamy K, Shah SA, Lim SM, et al. Computational approaches: discovery of GTPase HRas as prospective drug target for 1, 3-diazine scaffolds. BMC chemistry. 2019;13: 96. View at Publisher View at Google Scholar
Kakkar S, Kumar S, Lim SM, Ramasamy K, Mani V, Shah SA, et al. Design, synthesis and biological evaluation of 3-(2-aminooxazol-5-yl)-2 H-chromen-2-one derivatives. Chemistry Central Journal. 2018;12: 130. View at Publisher View at Google Scholar
Prev 1 2 3 4 5 6 7 Next »

Top